HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,881,539 | +6.9% | 21,004 | +1.6% | 0.67% | +8.0% |
| Q2 2023 | $1,760,525 | +4.7% | 20,678 | +1.8% | 0.62% | -5.5% |
| Q1 2023 | $1,681,563 | -20.1% | 20,321 | -24.1% | 0.66% | -32.0% |
| Q4 2022 | $2,105,696 | +9.6% | 26,773 | +3.2% | 0.97% | +2.9% |
| Q3 2022 | $1,921,000 | +287.3% | 25,943 | +421.8% | 0.94% | +128.0% |
| Q1 2020 | $496,000 | -0.6% | 4,972 | +14.6% | 0.41% | +14.7% |
| Q4 2019 | $499,000 | +1.2% | 4,340 | +10.9% | 0.36% | -14.0% |
| Q3 2019 | $493,000 | +11.5% | 3,912 | +6.4% | 0.42% | +32.1% |
| Q2 2019 | $442,000 | +68.1% | 3,677 | +22.2% | 0.32% | +56.7% |
| Q1 2019 | $263,000 | +4.0% | 3,010 | +19.2% | 0.20% | -11.7% |
| Q4 2018 | $253,000 | -10.0% | 2,525 | +3.0% | 0.23% | +9.0% |
| Q3 2018 | $281,000 | +25.4% | 2,452 | -1.7% | 0.21% | +15.3% |
| Q2 2018 | $224,000 | – | 2,494 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |